|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
2/13/24 Vanguard Group Inc. SC 13G/A 1:13K Revance Therapeutics, Inc. Toppan Merrill/FA
2/9/23 Vanguard Group Inc. SC 13G/A 1:12K Revance Therapeutics, Inc. Toppan Merrill/FA
2/10/22 Vanguard Group Inc. SC 13G 1:12K Revance Therapeutics, Inc. Toppan Merrill/FA
____________ | ¹ | Filing/Form Type: -K | | SC 13G | Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. |
|